IE39738B1 - Novel triamcinolone derivative - Google Patents
Novel triamcinolone derivativeInfo
- Publication number
- IE39738B1 IE39738B1 IE1704/74A IE170474A IE39738B1 IE 39738 B1 IE39738 B1 IE 39738B1 IE 1704/74 A IE1704/74 A IE 1704/74A IE 170474 A IE170474 A IE 170474A IE 39738 B1 IE39738 B1 IE 39738B1
- Authority
- IE
- Ireland
- Prior art keywords
- alpha
- triamcinolone derivative
- novel triamcinolone
- novel
- derivative
- Prior art date
Links
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical class O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38930273A | 1973-08-17 | 1973-08-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE39738L IE39738L (en) | 1975-02-17 |
| IE39738B1 true IE39738B1 (en) | 1978-12-20 |
Family
ID=23537694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1704/74A IE39738B1 (en) | 1973-08-17 | 1974-08-14 | Novel triamcinolone derivative |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4158055A (enExample) |
| JP (1) | JPS557407B2 (enExample) |
| BE (1) | BE818929A (enExample) |
| CH (1) | CH601353A5 (enExample) |
| CY (1) | CY946A (enExample) |
| DE (1) | DE2437847C3 (enExample) |
| FR (1) | FR2240738B1 (enExample) |
| GB (1) | GB1442925A (enExample) |
| HK (1) | HK44778A (enExample) |
| HU (1) | HU172213B (enExample) |
| IE (1) | IE39738B1 (enExample) |
| IL (1) | IL45200A (enExample) |
| KE (1) | KE2820A (enExample) |
| MY (1) | MY7800234A (enExample) |
| NL (1) | NL184899C (enExample) |
| PH (1) | PH12415A (enExample) |
| ZA (1) | ZA744259B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA763131B (en) * | 1975-05-27 | 1978-01-25 | Syntex Inc | Use of flunisolide to treat respiratory diseases |
| DE10326899A1 (de) * | 2003-06-14 | 2004-12-30 | Beiersdorf Ag | Kosmetische Zubereitungen mit stabilisierten Konservierungsmitteln |
| CA2537185A1 (en) * | 2003-08-29 | 2005-03-10 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-iv |
| WO2005028495A1 (en) * | 2003-09-24 | 2005-03-31 | Glaxo Group Limited | Anti-inflammatory glucocorticoids |
| WO2005051931A2 (en) * | 2003-11-26 | 2005-06-09 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
| EP1934219A1 (en) | 2005-09-16 | 2008-06-25 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| US20090221664A1 (en) | 2005-10-19 | 2009-09-03 | Abhijit Ray | Pharmaceutical compositions of muscarinic receptor antagonists |
| AU2006305620A1 (en) * | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
| KR20090069309A (ko) * | 2006-09-22 | 2009-06-30 | 랜박시 래보러터리스 리미티드 | 포스포디에스터라제 타입-ⅳ의 저해제 |
| EP2066661A2 (en) * | 2006-09-22 | 2009-06-10 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
| US20080207659A1 (en) * | 2007-02-15 | 2008-08-28 | Asit Kumar Chakraborti | Inhibitors of phosphodiesterase type 4 |
| CN103497185A (zh) | 2007-03-14 | 2014-01-08 | 兰贝克赛实验室有限公司 | 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物 |
| WO2008111009A1 (en) * | 2007-03-14 | 2008-09-18 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
| EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
| US8900626B2 (en) | 2011-06-20 | 2014-12-02 | Senju Usa, Inc. | Transdermal drug delivery system and method of using the same |
| CN113698448B (zh) * | 2021-10-29 | 2022-02-22 | 山东谷雨春生物科技有限公司 | 一种安西奈德的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB894810A (en) * | 1959-10-05 | 1962-04-26 | American Cyanamid Co | Aqueous pharmaceutical solutions containing anti-inflammatory steroids |
| US3048581A (en) * | 1960-04-25 | 1962-08-07 | Olin Mathieson | Acetals and ketals of 16, 17-dihydroxy steroids |
| GB928150A (en) * | 1961-02-08 | 1963-06-06 | Upjohn Co | Topical pharmaceutical compositions comprising steroids and flavonoids |
| US3053836A (en) * | 1961-07-14 | 1962-09-11 | Olin Mathieson | Acetals and ketals of 16alpha, 17alpha-dihydroxyprogesterones |
| US3541602A (en) * | 1968-07-29 | 1970-11-17 | Squibb & Sons Inc | Acetonides of 9-halogenated 3beta,11beta,10alpha,17alpha,21-pentahydroxypregnanes |
| GB1382614A (en) * | 1972-01-10 | 1975-02-05 | Squibb & Sons Inc | Steroid compositions |
| US3867528A (en) * | 1973-10-11 | 1975-02-18 | American Cyanamid Co | Steroidal topical cream base |
-
1974
- 1974-07-02 ZA ZA00744259A patent/ZA744259B/xx unknown
- 1974-07-04 GB GB2974874A patent/GB1442925A/en not_active Expired
- 1974-07-04 CY CY946A patent/CY946A/xx unknown
- 1974-07-05 IL IL45200A patent/IL45200A/xx unknown
- 1974-07-26 PH PH16097A patent/PH12415A/en unknown
- 1974-08-06 DE DE2437847A patent/DE2437847C3/de not_active Expired
- 1974-08-07 NL NLAANVRAGE7410613,A patent/NL184899C/xx not_active IP Right Cessation
- 1974-08-09 CH CH1089974A patent/CH601353A5/xx not_active IP Right Cessation
- 1974-08-12 FR FR7427912A patent/FR2240738B1/fr not_active Expired
- 1974-08-12 HU HU74AE00000421A patent/HU172213B/hu unknown
- 1974-08-14 IE IE1704/74A patent/IE39738B1/xx unknown
- 1974-08-16 BE BE147678A patent/BE818929A/xx not_active IP Right Cessation
- 1974-08-16 JP JP9348174A patent/JPS557407B2/ja not_active Expired
-
1976
- 1976-12-28 US US05/754,917 patent/US4158055A/en not_active Expired - Lifetime
-
1978
- 1978-02-28 KE KE2820A patent/KE2820A/xx unknown
- 1978-08-10 HK HK447/78A patent/HK44778A/xx unknown
- 1978-12-30 MY MY234/78A patent/MY7800234A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7410613A (nl) | 1975-02-19 |
| IE39738L (en) | 1975-02-17 |
| KE2820A (en) | 1978-03-10 |
| DE2437847B2 (de) | 1980-06-19 |
| US4158055A (en) | 1979-06-12 |
| JPS557407B2 (enExample) | 1980-02-25 |
| CH601353A5 (enExample) | 1978-07-14 |
| IL45200A0 (en) | 1974-11-29 |
| GB1442925A (en) | 1976-07-14 |
| HK44778A (en) | 1978-08-18 |
| DE2437847C3 (de) | 1981-03-12 |
| MY7800234A (en) | 1978-12-31 |
| NL184899B (nl) | 1989-07-03 |
| ZA744259B (en) | 1975-06-25 |
| JPS5058211A (enExample) | 1975-05-21 |
| BE818929A (fr) | 1975-02-17 |
| CY946A (en) | 1978-06-23 |
| FR2240738B1 (enExample) | 1980-04-11 |
| FR2240738A1 (enExample) | 1975-03-14 |
| PH12415A (en) | 1979-02-07 |
| DE2437847A1 (de) | 1975-02-27 |
| HU172213B (hu) | 1978-07-28 |
| NL184899C (nl) | 1989-12-01 |
| IL45200A (en) | 1978-08-31 |
| AU7073674A (en) | 1976-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE39738B1 (en) | Novel triamcinolone derivative | |
| IE39957L (en) | Steroid formulation | |
| AU508224B2 (en) | 9 21-dihalogeno-11 17 -dihydroxy-6 -fluro-16-methyl-pregna-1,4-diene-3,20-diones | |
| IE41287L (en) | Steroid pharmaceutical composition | |
| GB1115893A (en) | Pharmaceutical anti-allergic compositions | |
| IE811594L (en) | Pharmaceutical formulations | |
| CA1029017A (en) | Pharmaceutically active new leurosine derivatives and a process for the preparation thereof | |
| AU571073B2 (en) | Pharmaceutical composition of 9a, 11b-dichcoro-16a-methl-21-oxycarbonyl dicyclohexycmethycoxy pregna-1,4-diene-3,20-dione | |
| IE801561L (en) | A pregnane derivative | |
| IE34930B1 (en) | 21-esters of fluocinolone-acetonide | |
| ES375060A1 (es) | Un procedimiento de preparacion de 21-esteres de la triam- cinolona y de la acetonida de triamcinolona. | |
| CA866782A (en) | 16.alpha.-METHYL-9,11-OXIDO-17.alpha.,21-DIHYDROXY-1,4-PREGNADIENE-3,20-DIONE AND METHOD OF PREPARING THE SAME | |
| CA770593A (en) | 9.alpha.-HALO-11.beta.,17.alpha.,21-TRIHYDROXY-1,4-PREGNADIENE-3,20-DIONE AND 21-ESTERS AND PREPARATION | |
| CA738974A (en) | PROCESS OF PREPARING 16.alpha.-CHLOROMETHYL-.DELTA.1,4-PREGNADIENE-11.beta.,21-DIOL-3,20-DIONE AND ITS 21-ESTER | |
| CA641910A (en) | 12.alpha.-ALKYL-11.beta.,17.alpha.,21-TRIHYDROXY-1,4-PREGNADIENE-3,20-DIONE AND 9.alpha.-HALO SUBSTITUTED DERIVATIVES THEREOF | |
| CA734438A (en) | PROCEDE DE PREPARATION DU 3,20-DICETO 11.beta.,18-OXYDO 18.epsilon.-METHYL 21-HYDROXY .DELTA.4-PREGNENE ET DE SES ESTERS | |
| CA641909A (en) | 12.alpha.-ALKYL-17.alpha.,21-DIHYDROXY-1,4-PREGNADIENE-3,11,20-TRIONE AND 9.alpha.-HALO DERIVATIVES THEREOF | |
| AU499324B2 (en) | D-homo pregna 1, 4 diene-3, 11, 20 trione derivatives | |
| CA732602A (en) | 16.alpha.-CHLORO-11.beta.,17.alpha.-DIHYDROXY-1,4-PREGNADIENE-3,20-DIONES AND PROCESS OF PREPARATION | |
| CA907001A (en) | Process for the preparation of dl-19-norpregna-4,16-diene-3,20-dione and intermediate therefor | |
| CA866786A (en) | PROCESS FOR THE PREPARATION OF 16.alpha.-METHYL-9.alpha.-FLUORO-11.beta.,17.alpha.,21-TRIHYDROXY-1,4-PREGNADIENE-3,20-DIONE-21-ACYLATES | |
| GB1405519A (en) | Triamcinolone derivative | |
| CA734924A (en) | 16.beta.-METHYL PROGESTERONE-17.alpha.,21-DIOL 21-PHOSPHATE ESTERS AND ITS .DELTA.1,4-DERIVATIVES | |
| GB992581A (en) | Improvements in or relating to therapeutic compositions comprising steroids and thiamine derivatives | |
| CA742208A (en) | 17-MONOESTERS OF 17.alpha.,21-DIHYDROXY STEROIDS AND PROCESS FOR THE PREPARATION THEREOF |